These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24368753)

  • 1. QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Shah J; Morales G; Leung SW; Fornwalt B; Bailey AL; Ziada K; Sorrell VL; Zegarra MM; Thompson J; Hosn NA; Campbell CL; Gurley J; Anaya P; Booth DC; Di Biase L; Natale A; Smyth S; Moliterno DJ; Elayi CS;
    Europace; 2014 Jun; 16(6):803-11. PubMed ID: 24368753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis.
    Andrade JG; Roy D; Wyse DG; Dorian P; Talajic M; Leduc H; Cadrin-Tourigny J; Shohoudi A; Macle L; Thibault B; Guerra PG; Rivard L; Dubuc M; Khairy P
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):404-13. PubMed ID: 27074775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation.
    Björkenheim A; Brandes A; Andersson T; Magnuson A; Edvardsson N; Wandt B; Sloth Pedersen H; Poçi D
    Europace; 2014 Dec; 16(12):1772-8. PubMed ID: 25031234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial.
    Slee A; Saksena S
    Am Heart J; 2020 Feb; 220():1-11. PubMed ID: 31756389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented QRS in prediction of cardiac deaths and heart failure hospitalizations after myocardial infarction.
    Korhonen P; Husa T; Konttila T; Tierala I; Mäkijärvi M; Väänänen H; Ojanen J; Vehtari A; Toivonen L
    Ann Noninvasive Electrocardiol; 2010 Apr; 15(2):130-7. PubMed ID: 20522053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy.
    Andrade JG; Roy D; Wyse DG; Tardif JC; Talajic M; Leduc H; Tourigny JC; Shohoudi A; Dubuc M; Rivard L; Guerra PG; Thibault B; Dyrda K; Macle L; Khairy P
    Heart Rhythm; 2016 Jan; 13(1):54-61. PubMed ID: 26299677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.
    Gigliotti JN; Sidhu MS; Robert AM; Zipursky JS; Brown JR; Costa SP; Palac RT; Steckman DA; Malenka DJ; Kono AT; Greenberg ML
    Clin Cardiol; 2017 Oct; 40(10):861-864. PubMed ID: 28586090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of QRS morphology with cardiac structure and function in patients with heart failure.
    Pellicori P; Joseph AC; Zhang J; Lukaschuk E; Sherwi N; Bourantas CV; Loh H; Clark AL; Cleland JG
    Clin Res Cardiol; 2015 Nov; 104(11):935-45. PubMed ID: 25903113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
    Scovner KM; Correa S; Claggett BL; Barrett CD; Waikar SS; Solomon SD; Mc Causland FR
    Am J Nephrol; 2021; 52(5):412-419. PubMed ID: 33951623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias.
    Okafor O; Zegard A; van Dam P; Stegemann B; Qiu T; Marshall H; Leyva F
    J Am Heart Assoc; 2019 Nov; 8(21):e013539. PubMed ID: 31657269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
    Wang NC; Maggioni AP; Konstam MA; Zannad F; Krasa HB; Burnett JC; Grinfeld L; Swedberg K; Udelson JE; Cook T; Traver B; Zimmer C; Orlandi C; Gheorghiade M;
    JAMA; 2008 Jun; 299(22):2656-66. PubMed ID: 18544725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental changes in QRS duration predict mortality in patients with atrial fibrillation.
    Lin YJ; Liu YB; Chu CC
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1388-94. PubMed ID: 19761506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry.
    Chyou JY; Tay WT; Anand IS; Teng TK; Yap JJL; MacDonald MR; Chopra V; Loh SY; Shimizu W; Abidin IZ; ; Richards AM; Butler J; Lam CSP
    J Am Heart Assoc; 2021 Mar; 10(6):e017932. PubMed ID: 33719492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
    Kristensen SL; Castagno D; Shen L; Jhund PS; Docherty KF; Rørth R; Abraham WT; Desai AS; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Eur J Heart Fail; 2020 Dec; 22(12):2370-2379. PubMed ID: 32720404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
    Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.